Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-083220
Filing Date
2025-06-06
Accepted
2025-06-06 16:58:02
Documents
1
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5453
  Complete submission text file 0000950170-25-083220.txt   6928
Mailing Address 47 HULFISH STREET PRINCETON NJ 08542
Business Address 47 HULFISH STREET PRINCETON NJ 08542 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Issuer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3 TIMES SQAURE, 12TH FLOOR NEW YORK NY 10036
Business Address
SBLENDORIO GLENN (Reporting) CIK: 0001277478 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33497 | Film No.: 251031847